Conditional Approval of Drug for Pancreatitis in Dogs
Breaking News !! Just in time for the 2022 holiday season, when dogs often accidentally get into rich foods and trigger an acute pancreatitis attack, the FDA gave conditional approval to Panoquell-CA1 for 1 year, with the option for 4 additional annual renewals. The drug meant for injection during hospitalization for cases of pancreatitis in dogs has been approved in Japan since 2018. It’s made by Ishihara Sangyo Kaisha Ltd. Below, you’ll find some FAQs about this new medication and canine pancreatitis in general.
